Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries
- 7 September 2017
- journal article
- review article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 97 (3), 645-652
- https://doi.org/10.4269/ajtmh.16-0923
Abstract
Strongyloidiasis is an intestinal parasitic infection becoming increasingly important outside endemic areas, not only because of the high prevalence found in migrant populations, but also because immunosuppressed patients may suffer a potentially fatal disseminated disease. The aim of these guidelines is to provide evidence-based guidance for screening and treatment of strongyloidiasis in non-endemic areas. A panel of experts focused on three main clinical questions (who should be screened and how, how to treat), and reviewed pertinent literature available in international databases of medical literature and in documents released by relevant organizations/societies. A consensus of the experts’ opinion was sought when specific issues were not covered by evidence. In particular, six systematic reviews were retrieved and constituted the main support for this work. The evidence and consensus gathered led to recommendations addressing various aspects of the main questions. Grading of evidence and strength of recommendation were attributed to assess the quality of supporting evidence. The screening of individuals at risk of the infection should be performed before they develop any clinical complication. Moreover, in immunosuppressed patients, the screening should be mandatory. The screening is based on a simple and widely accessible technology and there is now a universally accepted treatment with a high efficacy rate. Therefore, the screening could be implemented as part of a screening program for migrants although further cost-effectiveness studies are required to better evaluate this strategy from a public health point of view.Keywords
This publication has 67 references indexed in Scilit:
- Strongyloides stercoralis: Global Distribution and Risk FactorsPLoS Neglected Tropical Diseases, 2013
- Severe strongyloidiasis: a systematic review of case reportsBMC Infectious Diseases, 2013
- Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralisCurrent Opinion in Infectious Diseases, 2012
- Is Human Immunodeficiency Virus Infection a Risk Factor for Strongyloides stercoralis Hyperinfection and DisseminationPLoS Neglected Tropical Diseases, 2012
- Randomized Clinical Trial on Ivermectin versus Thiabendazole for the Treatment of StrongyloidiasisPLoS Neglected Tropical Diseases, 2011
- Efficacy and Safety of Single and Double Doses of Ivermectin versus 7-Day High Dose Albendazole for Chronic StrongyloidiasisPLoS Neglected Tropical Diseases, 2011
- Travel-related schistosomiasis, strongyloidiasis, filariasis, and toxocariasis: the risk of infection and the diagnostic relevance of blood eosinophiliaBMC Infectious Diseases, 2011
- Strongyloides stercoralis: there but not seenCurrent Opinion in Infectious Diseases, 2010
- Strongyloidiasis in Transplant PatientsClinical Infectious Diseases, 2009
- Evaluation of an Indirect Immunofluorescence Assay for Strongyloidiasis as a Tool for Diagnosis and Follow-UpClinical and Vaccine Immunology, 2007